IRadimed Corp
NASDAQ:IRMD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
40.36
57.1909
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
IRadimed Corp
Wall Street
Price Targets
IRMD Price Targets Summary
IRadimed Corp
According to Wall Street analysts, the average 1-year price target for
IRMD
is 61.2 USD
with a low forecast of 60.6 USD and a high forecast of 63 USD.
IRMD Last Price Targets
IRadimed Corp
The latest public price target was made on Aug 2, 2024 by
Jason Wittes
from
Roth Capital
,
who expects
IRMD
stock to
rise by 11%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Jason Wittes
Roth Capital
|
60
USD
Upside 11% |
4 months ago
Aug 2, 2024
|
iRadimed price target lowered to $60 from $65 at Roth MKM
TheFly
|
Frank Takkinen
Loop Capital Markets
|
60
USD
Upside 11% |
6 months ago
Jun 17, 2024
|
Lake Street Capital Markets Reiterates Buy Rating on IRadimed Corp (IRMD)
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IRMD's stock price target?
Price Target
61.2
USD
According to Wall Street analysts, the average 1-year price target for
IRMD
is 61.2 USD
with a low forecast of 60.6 USD and a high forecast of 63 USD.
What is IRadimed Corp's Revenue forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
IRadimed Corp's revenue is
10%.
The projected
CAGR
for the next 3 years is
15%.
What is IRadimed Corp's Operating Income forecast?
Projected CAGR
21%
For the last 8 years the
compound annual growth rate for
IRadimed Corp's operating income is
7%.
The projected
CAGR
for the next 3 years is
21%.
What is IRadimed Corp's Net Income forecast?
Projected CAGR
17%
For the last 8 years the
compound annual growth rate for
IRadimed Corp's net income is
11%.
The projected
CAGR
for the next 3 years is
17%.
You don't have any saved screeners yet
